World's Best Scientists 2026 revealed!
Beverly S. Mitchell

Beverly S. Mitchell

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
12083
World Ranking
9850
National Ranking
4318

Beverly S. Mitchell publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Beverly S. Mitchell sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 182 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Beverly S. Mitchell D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Beverly S. Mitchell sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 64 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Beverly S. Mitchell is affiliated with Stanford University in the United States. Their research profile spans multiple aspects of biochemistry, genetics, and molecular biology, with significant contributions to medicine. The scientist's work is specifically rooted in molecular biology, physiology, surgery, epidemiology, and pediatrics, perinatology, and child health.

Their research topics revolve around biochemical and molecular research, adenosine and purinergic signaling, virus-related studies including cytomegalovirus and herpesvirus research, RNA modifications in cancer, neonatal health and biochemistry, genetics and neurodevelopmental disorders, and aspects of cancer diagnosis and treatment.

Frequent coauthors contributing to joint publications include Józef Spychała, Albert Zimmermann, Jing Gu, Lee M. Graves, and Min Huang. These collaborations underline a network of research partnerships across various experimental and clinical domains.

Publications by Beverly S. Mitchell appear regularly in venues such as UNC Libraries, the JNCI Journal of the National Cancer Institute, and the Journal of Clinical Oncology. The majority of their published work has been disseminated through UNC Libraries, reflecting a substantial body of research work.

Recent papers authored or coauthored by Beverly S. Mitchell include:

  • "Human Cytosolic 5'-Nucleotidase I: CHARACTERIZATION AND ROLE IN NUCLEOSIDE ANALOG RESISTANCE," 2021, UNC Libraries
  • "Tissue-specific Regulation of the Ecto-5'-nucleotidase Promoter: ROLE OF THE cAMP RESPONSE ELEMENT SITE IN MEDIATING REPRESSION BY THE UPSTREAM REGULATORY REGION," 2021, UNC Libraries
  • "One Step Further Toward Defining the Exceptional Cancer Responder," 2020, JNCI Journal of the National Cancer Institute
  • "Inhibition of Nucleoside Transport by p38 MAPK Inhibitors," 2021, UNC Libraries
  • "Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption," 2020, UNC Libraries

Best Publications

  • Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

    Robert Z. Orlowski;Thomas E. Stinchcombe;Beverly S. Mitchell;Thomas C. Shea

  • Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

    K. R. Rai;C. E. Freter;R. J. Mercier;M. R. Cooper

  • Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

    Robert Z. Orlowski;Robert Z. Orlowski;Peter M. Voorhees;Peter M. Voorhees;Reynaldo A. Garcia;Reynaldo A. Garcia;Melissa D. Hall;Melissa D. Hall

  • Association of DNA Polymerase μ (pol μ) with Ku and Ligase IV: Role for pol μ in End-Joining Double-Strand Break Repair

    Kiran N. Mahajan;Stephanie A. Nick McElhinny;Beverly S. Mitchell;Dale A. Ramsden

  • The 5′-nucleotidases as regulators of nucleotide and drug metabolism

    Sally Anne Hunsucker;Beverly S. Mitchell;Jozef Spychala

  • Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

    Daniel J. DeAngelo;Daohai Yu;Jeffrey L. Johnson;Steven E. Coutre

  • Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

    Beverly S. Mitchell;Edwin Mejias;Peter E. Daddona;William N. Kelley

  • Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

    J. Kurtzberg;T.J. Ernst;M.J. Keating;V. Gandhi

  • Cloning and expression of human deoxycytidine kinase cDNA.

    E G Chottiner;D S Shewach;N S Datta;E Ashcraft

  • Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

    L. A. Turka;J. D. Dayton;G. Sinclair;C. B. Thompson

  • Future cancer research priorities in the USA: a Lancet Oncology Commission

    Elizabeth M. Jaffee;Chi Van Dang;Chi Van Dang;David B. Agus;Brian M. Alexander

  • Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts

    Irene S. Kazmers;Beverly S. Mitchell;Peter E. Dadonna;Linda L. Wotring

  • Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene.

    Janet K. Owens;Donna S. Shewach;Buddy Ullman;Beverly S. Mitchell

  • Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases

    Jozef Spychala;Nabanita S. Datta;Kenji Takabayashi;Milton Datta

  • Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance.

    Sally Anne Hunsucker;Jozef Spychala;Beverly S. Mitchell

  • Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo.

    Yoshinobu Manome;Patrick Y. Wen;Yonghe Dong;Toshihide Tanaka

  • Regulation of the Interaction of Inosine Monophosphate Dehydrogenase with Mycophenolic Acid by GTP

    Yan Shan Ji;Jing Jin Gu;Alexander M. Makhov;Jack D. Griffith

  • Role of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast Cancer

    Jozef Spychala;Eduardo Lazarowski;Anna Ostapkowicz;Lanier H. Ayscue

  • ATP depletion as a consequence of adenosine deaminase inhibition in man.

    Martin F. E. Siaw;Beverly S. Mitchell;Charles A. Koller;Mary Sue Coleman

  • The proteasome--an emerging therapeutic target in cancer.

    Beverly S. Mitchell

Frequent Co-Authors

Donna S. Shewach
Donna S. Shewach University of Michigan–Ann Arbor
Jason Gotlib
Jason Gotlib Stanford University
Steven Coutre
Steven Coutre Stanford University
Lee M. Graves
Lee M. Graves University of North Carolina at Chapel Hill
William N. Kelley
William N. Kelley University of Pennsylvania
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
David Ginsburg
David Ginsburg University of Michigan–Ann Arbor
James M. Wilson
James M. Wilson University of Pennsylvania
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center
Peter L. Greenberg
Peter L. Greenberg Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Beverly S. Mitchell

Trending Scientists

Recently Published Articles